Key facts
| Price (PPV) | 51.50 MAD |
|---|---|
| Dispensing status | Unscheduled — no prescription needed |
| Composition (DCI) | théophylline |
| Class | Drugs for obstructive airway diseases |
| ATC code | R03DA04 |
| Manufacturer | SOTHEMA |
| Presentation | Boîte de 60 |
| Nature | Médicament |
| Hospital price | 32.20 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement symptomatique continu de l’asthme persistant et des autres bronchopneumopathies chroniques obstructives. La théophylline n’est pas le traitement de première intention de l’asthme.
Find an open pharmacy
On-call pharmacies near you
About Xanthium LP 300 mg
Xanthium LP 300 mg belongs to the drugs for obstructive airway diseases therapeutic class. In Morocco, this drug is marketed by SOTHEMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Xanthium LP 300 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Xanthium LP 300 mg
Answers to common questions from Moroccan patients about this drug.